Immune checkpoint inhibitor-induced musculoskeletal manifestations. A multicentre prospective study

BACKGROUND: Immune checkpoint inhibitors (ICI) are anti-cancer drugs that act by enhancing anti-tumour immunity. Due to their mechanism of action, they have been associated with immune related adverse events (Ir-AE), including musculoskeletal manifestations. AIM: To assess a) the prevalence, clinica...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mediterr J Rheumatol
Egile Nagusiak: Daoussis, Dimitrios, Melissaropoulos, Konstantinos, Dimitroulas, Theodoros, Andreadis, Haralambos, Christopoulou, Athina, Douganiotis, George, Makatsoris, Thomas, Koutras, Angelos, Georgiou, Panagiotis, Kalofonos, Haralabos
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The Mediterranean Journal of Rheumatology (MJR) 2020
Gaiak:
Research Protocol
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7362123/
https://ncbi.nlm.nih.gov/pubmed/32676566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31138/mjr.31.2.239
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak